BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21414096)

  • 1. Olfactory reference syndrome treated by blonanserin augmentation.
    Takekita Y; Kato M; Sakai S; Suwa A; Nishida K; Tajika A; Yoshimura M; Kinoshita T
    Psychiatry Clin Neurosci; 2011 Mar; 65(2):203-4. PubMed ID: 21414096
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
    Kumagai R; Ichimiya Y
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of catatonia successfully treated with ziprasidone, in a patient with DSM-IV delusional disorder.
    Angelopoulos EK; Corcondilas M; Kollias CT; Kioulos KT; Bergiannaki JD; Papadimitriou GN
    J Clin Psychopharmacol; 2010 Dec; 30(6):745-6. PubMed ID: 21057243
    [No Abstract]   [Full Text] [Related]  

  • 4. Parkinsonism with intramuscular ziprasidone.
    Bilal L; Tsai C; Gasper JJ; Ndlela JC
    Am J Psychiatry; 2005 Dec; 162(12):2392-3. PubMed ID: 16330610
    [No Abstract]   [Full Text] [Related]  

  • 5. Three cases of schizophrenia showing improvement after switching to blonanserin.
    Kurotaki N; Nobata H; Nonaka S; Nishihara K; Ozawa H
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):396-7. PubMed ID: 21682816
    [No Abstract]   [Full Text] [Related]  

  • 6. A long-term pilot study of pipothiazine palmitate in chronic schizophrenia.
    Villeneuve A; Pires A; Jus A; Lachance R; Drolet A
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):696-706. PubMed ID: 4404626
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and tolerability of Blonanserin in the patients with schizophrenia: a randomized, double-blind, risperidone-compared trial.
    Yang J; Bahk WM; Cho HS; Jeon YW; Jon DI; Jung HY; Kim CH; Kim HC; Kim YK; Kim YH; Kwon JS; Lee SY; Lee SH; Yi JS; Yoon BH; Kim SH
    Clin Neuropharmacol; 2010 Jul; 33(4):169-75. PubMed ID: 20661022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical differences among phenothiazines in schizophrenics. Introduction: specific indications for antipsychotics: elusive end of the rainbow.
    Hollister LE
    Adv Biochem Psychopharmacol; 1974; 9(0):667-73. PubMed ID: 4151921
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses.
    Salvesen C; Vaksdal K
    Behav Neuropsychiatry; 1973 Oct-1974 Mar; 5(7-12):3-7. PubMed ID: 4154740
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations].
    Sobolev ES; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(1):114-21. PubMed ID: 6111878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone augmentation of clozapine.
    McCarthy RH; Terkelsen KG
    Pharmacopsychiatry; 1995 Mar; 28(2):61-3. PubMed ID: 7542786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blonanserin in the treatment of delirium.
    Kato K; Yamada K; Maehara M; Akama F; Kimoto K; Saito M; Yano H; Ichimura A; Matsumoto H
    Psychiatry Clin Neurosci; 2011 Jun; 65(4):389-91. PubMed ID: 21569175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with amisulpride for the progression of olfactory reference syndrome to schizophrenia.
    Yeh YW; Chen CK; Huang SY; Kuo SC; Chen CY; Chen CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):579-80. PubMed ID: 19224708
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ziprasidone-augmentation of clozapine].
    Zink M; Mase E; Dressing H
    Psychiatr Prax; 2004 Jul; 31(5):259-61. PubMed ID: 15243877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
    Chan JH; Chen CH; Robson D; Tan HK
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):125-6. PubMed ID: 19154221
    [No Abstract]   [Full Text] [Related]  

  • 16. The position of blonanserin as a treatment for schizophrenia.
    Kishi T; Matsuda Y; Iwata N
    Asia Pac Psychiatry; 2014 Dec; 6(4):462. PubMed ID: 25425069
    [No Abstract]   [Full Text] [Related]  

  • 17. Blonanserin Augmentation for Treatment-Resistant Somatic Symptom Disorder: A Case Series.
    Nagoshi Y; Tominaga T; Fukui K
    Clin Neuropharmacol; 2016; 39(2):112-4. PubMed ID: 26818044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in quetiapine-induced hypoglycemia following a switch to blonanserin.
    Suzuki Y; Tsuneyama N; Sugai T; Fukui N; Watanabe J; Ono S; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Jun; 66(4):370-1. PubMed ID: 22624745
    [No Abstract]   [Full Text] [Related]  

  • 19. [The changes in the interaction of the brain hemispheres in the course of drug therapy of psychosis].
    Ivanov OV
    Zh Evol Biokhim Fiziol; 2003; 39(1):104-9. PubMed ID: 12739274
    [No Abstract]   [Full Text] [Related]  

  • 20. Case of delirium complicated with pneumonia that improved with blonanserin administration.
    Andoh H; Kato K; Sato R; Akama F; Sakaguchi T; Matsumoto H
    Psychiatry Clin Neurosci; 2010 Oct; 64(5):588-9. PubMed ID: 20923437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.